Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
UMediC Group Berhad is a Malaysia-based investment holding company engaged in the development, manufacturing, and marketing of medical consumables, as well as the distribution of laboratory equipment and consumables. It operates in two segments: Marketing and Distribution, and Manufacturing. The Marketing and Distribution segment specializes in the marketing and distribution of medical devices, as well as the provision of after-sales services, to both public and private hospitals, healthcare service providers, and non-medical business entities. The Manufacturing segment includes the development, manufacturing, and marketing of medical consumables. Its products include the HYDROX series prefilled humidifiers, the HYDROX prefilled nebulizers, the AIRDROX series inhaler spacers, and the FLEXIDROX water for inhalation bags. Its services include clinical training on equipment, planned preventive maintenance, equipment pre-checks, equipment servicing and repair, and other related services.
Oil and gas
OVERWEIGHT
HONG LEONG INVESTMENT BANK RESEARCH (SEPT 14): Brent has returned above US$100 per barrel as risks rise across Hormuz, Bab el-Mandeb and Saudi’s E...
UMediC Group Bhd's order book rose 17% quarter-on-quarter to RM18mil as at July, providing solid near-term revenue visibility as the group targets a 10% to 15% capacity expansion in the financial year 2027 (FY27).
Rising plastic input costs may weigh on UMediC Group Bhd's (UMC) near-term outlook, but analysts expect its earnings to strengthen in financial year 2027 (FY27), led by the distribution division.
PETALING JAYA: UMediC Group Bhd expects its expanded manufacturing capabilities and growing exposure to specialised healthcare segments to support its next phase of growth after fourth-quarter revenue jumped 52.1% year-on-year to RM18.7mil.
🏥 UMediC Group Berhad (UMC): Is Q4 FY2026 a Genuine Turnaround or a Temporary Bump?
UMediC’s share price has slid from around RM0.75–RM0.80 in late 2023 down to RM0.31 as of September 2026. With the release of its Q4 FY2026 financial report showing record quarterly revenue, is the business finally turning the corner?